Yuji Yamada
Overview
Explore the profile of Yuji Yamada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
240
Citations
1162
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubota R, Uchino T, Okubo R, Akiyama H, Okano H, Yamada Y, et al.
Schizophr Res
. 2025 Mar;
278:26-34.
PMID: 40088604
Background: Experts have categorized social cognition in schizophrenia into four domains: theory of mind, emotion processing, social perception, and attributional bias. However, previous factor analyses based on this categorization have...
2.
Ueda Y, Kiyonaka S, Selfors L, Inoue K, Harada H, Doura T, et al.
Nat Cell Biol
. 2025 Feb;
27(3):530-543.
PMID: 39984655
Intratumour heterogeneity represents the hierarchical integration of genetic, phenotypic and microenvironmental heterogeneity. Although single-cell sequencing has clarified genetic and phenotypic variability, the heterogeneity of nongenetic, microenvironmental factors remains elusive. Here,...
3.
Corbera S, Kurtz M, Achim A, Agostoni G, Amado I, Assaf M, et al.
Eur Psychiatry
. 2025 Jan;
68(1):e9.
PMID: 39812093
In the last decades, research from cognitive science, clinical psychology, psychiatry, and social neuroscience has provided mounting evidence that several social cognitive abilities are impaired in people with schizophrenia and...
4.
Murayama A, Yamada Y, Tarras E, Nguyen D, Marshall D
J Am Med Dir Assoc
. 2024 Dec;
26(2):105426.
PMID: 39736475
No abstract available.
5.
Hisano H, Shoji K, Matsui T, Kato H, Fukui K, Kano M, et al.
J Infect Chemother
. 2024 Dec;
31(3):102600.
PMID: 39725073
Subsequent bacteremia developed in 14 % of patients with positive catheter tip cultures but concurrent negative blood cultures. The occurrence of subsequent bacteremia did not differ significantly by pathogens (Staphylococcus...
6.
Wada A, Yamada R, Yamada Y, Sumiyoshi C, Hashimoto R, Matsumoto J, et al.
Schizophr Res
. 2024 Dec;
275():131-136.
PMID: 39721222
Background: Cognitive impairment is a cardinal feature in patients with schizophrenia and leads to poor social functioning. Recently, the treatment of schizophrenia has evolved to include the goal of improving...
7.
Takeda K, Kashiwagi H, Takanobu K, Kubota R, Naoe R, Yamada Y, et al.
Neuropsychopharmacol Rep
. 2024 Nov;
45(1):e12505.
PMID: 39592247
Aim: Psychopharmacotherapy plays an important role in the treatment of mentally disordered offenders (MDOs) with schizophrenia spectrum disorders. However, there have been few large-scale reports from multiple forensic psychiatric wards....
8.
Funato M, Iwata R, Ando T, Takeuchi M, Horibe Y, Funato T, et al.
Brain Dev
. 2024 Nov;
47(1):104297.
PMID: 39549635
Background: Duchenne muscular dystrophy (DMD) is a hereditary neuromuscular disorder characterized by severe, progressive muscle wasting. Viltolarsen, a formulation consisting of exon 53-skipping antisense oligonucleotides of the dystrophin gene, has...
9.
Okamoto T, Doi K, Ogura S, Kusunose M, Takahashi K, Fujimoto T, et al.
IJU Case Rep
. 2024 Nov;
7(6):503-505.
PMID: 39498185
Introduction: Xanthogranulomatous prostatitis is a very rare benign inflammatory lesion of the prostate that may be similar to prostatic carcinoma in clinical presentation and radiological characteristics. Case Presentation: A 77-year-old...
10.
Uchino T, Akiyama H, Okubo R, Wada I, Aoki A, Nohara M, et al.
Schizophrenia (Heidelb)
. 2024 Oct;
10(1):94.
PMID: 39472633
Intervention for social cognition could be key to improving social functioning in patients with schizophrenia. A first step towards its clinical implementation involves interviewing patients about their subjective difficulties with...